Skip to content

Regulatory effect of novel tDCS neurofeedback technology on psychiatric drug dependence

Regulatory effect of novel tDCS neurofeedback technology on psychiatric drug dependence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066404
Enrollment
Unknown
Registered
2022-12-05
Start date
2022-12-05
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychiatric drug dependence

Interventions

Insomnia group A:tDCS
Insomnia group B:Benzodiazepines
Insomnia group C:tDCS + benzodiazepines

Sponsors

Hefei Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-55 years old; 2) normal visual acuity or corrected vision; 3) Normal color vision; 4) Right-handed; 5) No excessive caffeine, alcohol, nicotine intake, that is, up to 5 alcoholic beverages per week, up to 1 cup of coffee or 1 caffeinated beverage per day, up to 1 cigarette per day; 6) The subject should be clinically diagnosed as primary insomnia but have no other psychiatric diseases.

Exclusion criteria

Exclusion criteria: 1) History of diagnosis and treatment of cognitive disorders, such as ADHD, mental retardation, cognitive impairment, etc.; 2) History of diagnosis of neurological or psychiatric diseases, such as obsessive-compulsive disorder, anxiety disorder, personality disorder, etc.; 3) History of mental trauma or head trauma, such as major blows in life, electroconvulsive therapy, syncope; 4) Have taken drugs or substances that affect the central nervous system within the past 2 weeks, such as antipsychotic drugs, alcohol addiction, tobacco addiction; 5) Shift work in the past 3 months, and flights across time zones in the previous 1 month; 6) Participants who are currently participating in other experiments, and who are unwilling or unable to complete the entire experiment.

Design outcomes

Primary

MeasureTime frame
EEG;MRI;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index;Athens Insomnia Scale;Cambridge Neuropsychological Test Automatic Battery;Wechsler Memory Scale;Wisconsin Card Sorting Test;Montreal Cognitive Assessment;

Countries

China

Contacts

Public ContactLi Wan

Hefei Fourth People's Hospital

wanli@ahmu.edu.cn+86 0551 6361 6273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026